| Medical Board Says MDs Cheated The American Board of Internal Medicine is moving against nearly 140 doctors who it says cheated on the organization's certification exams. online.wsj.com |
Parents Seek Vaccination Exemptions Some parents in Greater New York are so concerned about the safety of childhood vaccines that they are seeking to exempt their children from school immunization requirements. online.wsj.com |
PPD Appoints Neil McCullough, Ph.D., Vice President of Quality Management Systems (Business Wire) WILMINGTON, N.C.----PPD, Inc. today announced it has named Neil McCullough, Ph.D., as vice president of quality management systems. In this role, Dr. McCullough will provide strategic direction for quality management across all lines of business and ensure full compliance with global regulations guiding the biopharmaceutical industry. us.rd.yahoo.com |
4 Lessons From a Review of Arena Articles Ketan Desai submits:Arena (ARNA) took its share of lumps Thursday after the FDA advisory panel recommended against approval. Though it did not trade then, it was down Friday pre-market to approximately $2.12. And to think it was about $8 just a few weeks ago. What was fascinating about this run up and downfall was the number of posts and comments on Seeking Alpha about Arena.I counted the number of articles and blogs by writers over the past six months. I counted both blogs and articles, since some blogs could have been accepted by the editors as articles but were not. Fourteen authors had opined on Arena, some more than once. Of the fourteen, only five were negative, and nine were positive. The five who were negative got plenty of comments, most of them personal, and only a few giving rational counter arguments. Since they were correct, I for one tip my hat to Joseph Krueger, Penn Bioinvestor, Baskin Financial, Tungsten, and John Tucker. I also compliment some of the latter group for remaining calm and civilized despite some vitriolic attacks on them.Complete Story » seekingalpha.com |
Biopharmaceutical Bioniche Life Raising Funds to Expand Oncology Drug Production Proactive Investor submits: Canadian biopharmaceutical company Bioniche Life Sciences (BNHLF.PK) said Monday that it is offering up to 20 million new common shares, under two concurrent financings to be held in Canada and Australia. The share offer in Australia is the lead-up to our plan to list the company on the Australian Securities Exchange,Complete Story » seekingalpha.com |